CD97 stabilises the immunological synapse between dendritic cells and T cells and is targeted for degradation by the Salmonella effector SteD
Cerny, Ondrej, Godlee, Camilla, Tocci, Romina, Cross, Nancy E, Shi, Haoran, Williamson, James C, Alix, Eric, Lehner, Paul J, Holden, David W
Published in PLoS pathogens (01.07.2021)
Published in PLoS pathogens (01.07.2021)
Get full text
Journal Article
US norms for six generic health-related quality-of-life indexes from the National Health Measurement study
Fryback, Dennis G, Dunham, Nancy Cross, Palta, Mari, Hanmer, Janel, Buechner, Jennifer, Cherepanov, Dasha, Herrington, Shani A, Hays, Ron D, Kaplan, Robert M, Ganiats, Theodore G, Feeny, David, Kind, Paul
Published in Medical care (01.12.2007)
Published in Medical care (01.12.2007)
Get more information
Journal Article
Socioeconomic status and age variations in health-related quality of life: results from the national health measurement study
Robert, Stephanie A, Cherepanov, Dasha, Palta, Mari, Dunham, Nancy Cross, Feeny, David, Fryback, Dennis G
Published in The journals of gerontology. Series B, Psychological sciences and social sciences (01.05.2009)
Published in The journals of gerontology. Series B, Psychological sciences and social sciences (01.05.2009)
Get more information
Journal Article
Risk of falls after hospital discharge
Mahoney, J, Sager, M, Dunham, N C, Johnson, J
Published in Journal of the American Geriatrics Society (JAGS) (01.03.1994)
Published in Journal of the American Geriatrics Society (JAGS) (01.03.1994)
Get more information
Journal Article
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
Papp, Kim A., Merola, Joseph F., Gottlieb, Alice B., Griffiths, Christopher E.M., Cross, Nancy, Peterson, Luke, Cioffi, Christopher, Blauvelt, Andrew
Published in Journal of the American Academy of Dermatology (01.08.2018)
Published in Journal of the American Academy of Dermatology (01.08.2018)
Get full text
Journal Article
Bimekizumab versus Adalimumab in Plaque Psoriasis
Warren, Richard B, Blauvelt, Andrew, Bagel, Jerry, Papp, Kim A, Yamauchi, Paul, Armstrong, April, Langley, Richard G, Vanvoorden, Veerle, De Cuyper, Dirk, Cioffi, Christopher, Peterson, Luke, Cross, Nancy, Reich, Kristian
Published in The New England journal of medicine (08.07.2021)
Published in The New England journal of medicine (08.07.2021)
Get full text
Journal Article
52668 Bimekizumab efficacy and safety in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: 3-year results from BE BRIGHT, a multicenter, open-label, phase 3 study
Okubo, Yukari, Tada, Yayoi, Takahashi, Hidetoshi, Abe, Masatoshi, Yamanaka, Keiichi, Tilt, Nicola, Cross, Nancy, Deherder, Delphine, Matano, Mizuho, Nakagawa, Hidemi
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
Bimekizumab for patients with moderate to severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled, phase 2b extension study
Blauvelt, Andrew, Papp, Kim A., Merola, Joseph F., Gottlieb, Alice B., Cross, Nancy, Madden, Cynthia, Wang, Maggie, Cioffi, Christopher, Griffiths, Christopher E.M.
Published in Journal of the American Academy of Dermatology (01.11.2020)
Published in Journal of the American Academy of Dermatology (01.11.2020)
Get full text
Journal Article
Measurement of activities of daily living in hospitalized elderly: a comparison of self-report and performance-based methods
Sager, M A, Dunham, N C, Schwantes, A, Mecum, L, Halverson, K, Harlowe, D
Published in Journal of the American Geriatrics Society (JAGS) (01.05.1992)
Published in Journal of the American Geriatrics Society (JAGS) (01.05.1992)
Get more information
Journal Article
Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis: Pooled Results From Phase 2 and Phase 3 Randomized Clinical Trials
Gordon, Kenneth B, Langley, Richard G, Warren, Richard B, Okubo, Yukari, Stein Gold, Linda, Merola, Joseph F, Peterson, Luke, Wixted, Krista, Cross, Nancy, Deherder, Delphine, Thaçi, Diamant
Published in JAMA dermatology (Chicago, Ill.) (01.07.2022)
Published in JAMA dermatology (Chicago, Ill.) (01.07.2022)
Get more information
Journal Article
27380 Bimekizumab efficacy in patients with moderate to severe plaque psoriasis during the randomized withdrawal and retreatment phase of BE READY, a phase 3 trial
Blauvelt, Andrew, Wu, Jashin J., Reich, Kristian, Gooderham, Melinda, Lebwohl, Mark, White, Katy, Cross, Nancy, Cioffi, Christopher, Papp, Kim A.
Published in Journal of the American Academy of Dermatology (01.09.2021)
Published in Journal of the American Academy of Dermatology (01.09.2021)
Get full text
Journal Article
Bimekizumab safety in moderate to severe plaque psoriasis: Rates of hepatic events and changes in liver parameters over 2 years in randomized phase 3/3b trials
Lebwohl, Mark, Merola, Joseph F., Strober, Bruce, Armstrong, April, Yoshizaki, Ayumi, Gisondi, Paolo, Szilagyi, Balint, Peterson, Luke, de Cuyper, Dirk, Cross, Nancy, Davies, Owen, Gottlieb, Alice B.
Published in Journal of the American Academy of Dermatology (01.08.2024)
Published in Journal of the American Academy of Dermatology (01.08.2024)
Get full text
Journal Article
Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs
Cross, Nancy, van Steen, Cécile, Zegaoui, Yasmina, Satherley, Andrew, Angelillo, Luigi
Published in Clinical ophthalmology (Auckland, N.Z.) (01.01.2022)
Published in Clinical ophthalmology (Auckland, N.Z.) (01.01.2022)
Get full text
Journal Article
14020 Durability of responses with bimekizumab, a selective dual inhibitor of interleukin-17A and -17F, in moderate to severe chronic plaque psoriasis in a 60-week randomized, double-blinded, phase 2b study (BE ABLE 2)
Blauvelt, Andrew, Merola, Joseph F., Papp, Kim Alexander, Gooderham, Melinda, Gottlieb, Alice B., Cioffi, Christopher, Peterson, Luke, Cross, Nancy, Griffiths, Christopher, Thaci, Diamant
Published in Journal of the American Academy of Dermatology (01.12.2020)
Published in Journal of the American Academy of Dermatology (01.12.2020)
Get full text
Journal Article
Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo‐controlled, double‐blinded study
Youn, Sang Woong, Jo, Seong Jin, Park, Chul Jong, Kim, Dong Hyun, Shin, Bong Seok, Jeong, Ki Heon, Bang, Chul Hwan, Cross, Nancy, Thirlwell, Jackie, Hoepken, Bengt
Published in Journal of dermatology (01.11.2024)
Published in Journal of dermatology (01.11.2024)
Get full text
Journal Article
Current and Future Treatment of Retinitis Pigmentosa
Cross, Nancy, van Steen, Cecile, Zegaoui, Yasmina, Satherley, Andrew, Angelillo, Luigi
Published in Clinical ophthalmology (Auckland, N.Z.) (31.08.2022)
Published in Clinical ophthalmology (Auckland, N.Z.) (31.08.2022)
Get full text
Journal Article
Bimekizumab versus Adalimumab in Plaque Psoriasis
Griffith, Shantelle K, Ahn, Grace S, Wu, Jashin J, Warren, Richard B, Cioffi, Christopher, Peterson, Luke
Published in The New England journal of medicine (16.09.2021)
Published in The New England journal of medicine (16.09.2021)
Get full text
Journal Article
Bimekizumab 3-year Efficacy in High-Impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from Five Phase 3/3b Trials
Merola, Joseph F., Conrad, Curdin, Hampton, Philip, Lambert, Jo, Gottlieb, Alice B., Tilt, Nicola, Cross, Nancy, Wiegratz, Susanne, Gooderham, Melinda
Published in Skin (Milwood, N.Y.) (16.01.2024)
Published in Skin (Milwood, N.Y.) (16.01.2024)
Get full text
Journal Article